Form 8-K - Current report:
SEC Accession No. 0001023024-06-000005
Filing Date
2006-02-01
Accepted
2006-02-01 16:07:01
Documents
2
Period of Report
2006-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 3RD AMENDEMENT TO BIOSANTE LEASE biosantelease.htm 8-K 28739
2 THIRD AMENDMENT TO BIOSANTE LEASE thirdamendment.htm EX-10.1 20854
  Complete submission text file 0001023024-06-000005.txt   51235
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 06569814
SIC: 2836 Biological Products, (No Diagnostic Substances)